ClinicalTrials.gg

Drug

Givosiran clinical trials

Also written GIVLAARI and ALN-AS1.

studies test it
4
open now
0
in phase 3
1
first study started
2015

How studies write it

Studies that test it under each name

Name

Brand

Development codes

Studies by the year they started

4 studies that test it; most in 2015 (1)

Studies that test givosiran, by start year
YearStudies
20151
20161
20171
20181

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
1
Phase 3
1

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 4 · Other 0

Alnylam Pharmaceuticals (4)

Studies

Open first, then newest update. How each study uses givosiran is read from its arms, and is right about nine times in ten.

Testing it · 4

Codes

What other systems call givosiran · ClinicalTrials.gg INT001060

  • MeSH (NLM) C000630124givosiranOne source NLM
  • UNII (FDA) ROV204583WGIVOSIRANConfirmed FDA, NLM, Wikidata
  • RxNorm 2265712Confirmed FDA, Wikidata
  • Wikidata Q56297041givosiranConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C146805GivosiranOne source FDA
  • DrugBank DB15066One source Wikidata

Also registered as givosiran sodium (UNII 5XE21E41RT · RxNorm 2265859).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.